Improvement of chemosensitivity and inhibition of migration via targeting tumor epithelial-to-mesenchymal transition cells by ADH-1-modified liposomes

References

• Acloque H, Adams MS, Fishwick K, et al. (2009). Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 119:1438–49.
   PubMed Web of Science ®Google Scholar
• Allen TM. (1998). Liposomal drug formulations. Rationale for development and what we can expect for the future. Drugs 56:747–56.
   PubMed Web of Science ®Google Scholar
• Augustine CK, Yoshimoto Y, Gupta M, et al. (2008). Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment. Cancer Res 68:3777–84.
   PubMed Web of Science ®Google Scholar
• Blanco E, Hsiao A, Mann AP, et al. (2011). Nanomedicine in cancer therapy: innovative trends and prospects. Cancer Sci 102:1247–52.
   PubMed Web of Science ®Google Scholar
• Burden-Gulley SM, Gates TJ, Craig SE, et al. (2009). Novel peptide mimetic small molecules of the HAV motif in N-cadherin inhibit N-cadherin-mediated neurite outgrowth and cell adhesion. Peptides 30:2380–7.
   PubMed Web of Science ®Google Scholar
• Chambers AF, Groom AC, MacDonald IC. (2002). Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563–72.
   PubMed Web of Science ®Google Scholar
• Cheng GZ, Chan J, Wang Q, et al. (2007). Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 67:1979–87.
   PubMed Web of Science ®Google Scholar
• De Wever O, Westbroek W, Verloes A, Bloemen N, Bracke M, Gespach C, Bruyneel E, Mareel M. (2004). Critical role of N-cadherin in myofibroblast invasion and migration in vitro stimulated by colon-cancer-cell-derived TGF-beta or wounding. J Cell Sci 117:4691–703.
   PubMed Web of Science ®Google Scholar
• Geers B, De Wever O, Demeester J, et al. (2013). Targeted liposome-loaded microbubbles for cell-specific ultrasound-triggered drug delivery. Small 9:4027–35.
   PubMed Web of Science ®Google Scholar
• Guo Z, He B, Jin H, et al. (2014). Targeting efficiency of RGD-modified nanocarriers with different ligand intervals in response to integrin alphavbeta3 clustering. Biomaterials 35:6106–17.
   PubMed Web of Science ®Google Scholar
• Guo Z, He B, Yuan L, et al. (2015). Dual targeting for metastatic breast cancer and tumor neovasculature by EphA2-mediated nanocarriers. Int J Pharmaceu 493:380–9.
   PubMed Web of Science ®Google Scholar
• Halbleib JM, Nelson WJ. (2006). Cadherins in development: cell adhesion, sorting, and tissue morphogenesis. Genes Dev 20:3199–214.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. (2000). The hallmarks of cancer. Cell 100:57–70.
   PubMed Web of Science ®Google Scholar
• Hazan RB, Phillips GR, Qiao RF, et al. (2000). Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148:779–90.
   PubMed Web of Science ®Google Scholar
• Hazan RB, Qiao R, Keren R, et al. (2004). Cadherin switch in tumor progression. Ann N Y Acad Sci 1014:155–63.
   PubMed Web of Science ®Google Scholar
• Hugo H, Ackland ML, Blick T, et al. (2007). Epithelial–mesenchymal and mesenchymal–epithelial transitions in carcinoma progression. J Cell Physiol 213:374–83.
   PubMed Web of Science ®Google Scholar
• Kerbel RS. (1990). Growth dominance of the metastatic cancer cell: cellular and molecular aspects. Adv Cancer Res 55:87–132.
   PubMedGoogle Scholar
• Li QQ, Wang WJ, Xu JD, et al. (2007a). Involvement of CD147 in regulation of multidrug resistance to P-gp substrate drugs and in vitro invasion in breast cancer cells. Cancer Sci 98:1064–9.
   PubMed Web of Science ®Google Scholar
• Li QQ, Wang WJ, Xu JD, et al. (2007b). Up-regulation of CD147 and matrix metalloproteinase-2, -9 induced by P-glycoprotein substrates in multidrug resistant breast cancer cells. Cancer Sci 98:1767–74.
   PubMed Web of Science ®Google Scholar
• Li QQ, Xu JD, Wang WJ, et al. (2009). Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells. Clin Cancer Res 15:2657–65.
   PubMed Web of Science ®Google Scholar
• Li S, Wang K, Shi Y, et al. (2016). Novel biological functions of ZIF-NP as a delivery vehicle: high pulmonary accumulation, favorable biocompatibility, and improved therapeutic outcome. Adv Funct Mater 26:2715–27.
   Web of Science ®Google Scholar
• Marcucci F, Lefoulon F. (2004). Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress. Drug Discov Today 9:219–28.
   PubMed Web of Science ®Google Scholar
• Nieto MA. (2009). Epithelial-Mesenchymal transitions in development and disease: old views and new perspectives. Int J Dev Biol 53:1541–7.
   PubMed Web of Science ®Google Scholar
• Qi X, Zhang L, Lu X. (2016). New Insights into the Epithelial-to-Mesenchymal transition in cancer. Trend Pharmacol Sci 37:246–8.
   PubMed Web of Science ®Google Scholar
• Qin C, He B, Dai W, et al. (2014). The impact of a chlorotoxin-modified liposome system on receptor MMP-2 and the receptor-associated protein ClC-3. Biomaterials 35:5908–20.
   PubMed Web of Science ®Google Scholar
• Su ZZ, Austin VN, Zimmer SG, Fisher PB. (1993). Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Oncogene 8:1211–19.
   PubMed Web of Science ®Google Scholar
• Thiery JP, Acloque H, Huang RY, Nieto MA. (2009). Epithelial-mesenchymal transitions in development and disease. Cell 139:871–90.
   PubMed Web of Science ®Google Scholar
• Voulgari A, Pintzas A. (2009). Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochimica Et Biophysica Acta 1796:75–90.
   PubMed Web of Science ®Google Scholar
• Wang X, Ling MT, Guan XY, et al. (2004). Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells. Oncogene 23:474–82.
   PubMed Web of Science ®Google Scholar
• Wang XX, Li YB, Yao HJ, et al. (2011). The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells. Biomaterials 32:5673–87.
   PubMed Web of Science ®Google Scholar
• Wheelock MJ, Shintani Y, Maeda M, et al. (2008). Cadherin switching. J Cell Sci 121:727–35.
   PubMed Web of Science ®Google Scholar
• Xiang Y, Liang L, Wang X, et al. (2011). Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes. J Controlled Release 152:402–10.
   PubMed Web of Science ®Google Scholar
• Yang AD, Fan F, Camp ER, et al. (2006). Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res 12:4147–53.
   PubMed Web of Science ®Google Scholar
• Yang JM, Xu Z, Wu H, et al. (2003). Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Molecul Cancer Res 1:420–7.
   PubMed Web of Science ®Google Scholar
• Yang X, Shi R, Zhang J. (2016). Co-expression and clinical utility of Snail and N-cadherin in papillary thyroid carcinoma. Tumor Biol 37:413–17.
   PubMedGoogle Scholar
• Ye X, Tam WL, Shibue T, et al. (2015). Distinct EMT programs control normal mammary stem cells and tumour-initiating cells. Nature 525:256–60.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang H, Wang X, et al. (2012). The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles. Biomaterials 33:679–91.
   PubMed Web of Science ®Google Scholar
• Zheng X, Carstens JL, Kim J, et al. (2015). Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 527:525–30.
   PubMed Web of Science ®Google Scholar